AMETEK, Inc. (NYSE:AME) VP Thomas M. Montgomery Sells 5,602 Shares of Stock

AMETEK, Inc. (NYSE:AME) VP Thomas M. Montgomery sold 5,602 shares of the firm’s stock in a transaction dated Thursday, June 27th. The shares were sold at an average price of $88.50, for a total transaction of $495,777.00. Following the completion of the sale, the vice president now owns 26,419 shares of the company’s stock, valued at approximately $2,338,081.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

AMETEK stock traded down $0.19 during trading on Friday, reaching $88.71. The company had a trading volume of 1,169,560 shares, compared to its average volume of 1,266,547. AMETEK, Inc. has a 12-month low of $63.14 and a 12-month high of $92.30. The business’s 50 day moving average price is $87.80. The stock has a market capitalization of $20.21 billion, a price-to-earnings ratio of 26.96, a price-to-earnings-growth ratio of 2.26 and a beta of 1.24. The company has a quick ratio of 1.27, a current ratio of 1.91 and a debt-to-equity ratio of 0.53.

AMETEK (NYSE:AME) last released its earnings results on Wednesday, May 1st. The technology company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.03. AMETEK had a net margin of 16.14% and a return on equity of 18.56%. The firm had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.28 billion. During the same period in the previous year, the firm earned $0.79 earnings per share. AMETEK’s revenue was up 9.8% compared to the same quarter last year. Equities analysts expect that AMETEK, Inc. will post 4.08 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were given a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, June 13th. This represents a $0.56 dividend on an annualized basis and a yield of 0.63%. AMETEK’s dividend payout ratio (DPR) is 17.02%.

Several analysts recently commented on the stock. ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Morgan Stanley set a $226.00 target price on shares of S&P Global and gave the company a “hold” rating in a report on Friday, May 3rd. DA Davidson upgraded shares of Domtar from a “neutral” rating to a “buy” rating in a report on Thursday, May 2nd. Zacks Investment Research downgraded shares of Essential Properties Realty Trust from a “buy” rating to a “hold” rating in a report on Thursday, June 13th. Finally, BMO Capital Markets upgraded shares of TMAC Resources from a “market perform” rating to an “outperform” rating in a report on Thursday, May 2nd. Fifteen equities research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus target price of $91.50.

A number of hedge funds have recently made changes to their positions in AME. Norges Bank acquired a new position in AMETEK during the fourth quarter valued at approximately $134,370,000. JPMorgan Chase & Co. lifted its position in AMETEK by 24.8% during the first quarter. JPMorgan Chase & Co. now owns 4,147,050 shares of the technology company’s stock valued at $344,081,000 after buying an additional 823,704 shares in the last quarter. Argent Capital Management LLC acquired a new position in AMETEK during the first quarter valued at approximately $49,936,000. FMR LLC lifted its position in AMETEK by 4.2% during the fourth quarter. FMR LLC now owns 9,274,980 shares of the technology company’s stock valued at $627,916,000 after buying an additional 372,219 shares in the last quarter. Finally, Marshall Wace North America L.P. lifted its position in AMETEK by 332.0% during the first quarter. Marshall Wace North America L.P. now owns 437,986 shares of the technology company’s stock valued at $36,340,000 after buying an additional 336,593 shares in the last quarter. 85.73% of the stock is currently owned by hedge funds and other institutional investors.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Recommended Story: Elliott Wave Theory

Insider Buying and Selling by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.